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Introduction
During the past few decades, antibiotic-resistance of bacteria has assumed the proportion of a global
crisis. The discovery of new antibiotics is not matching the rate of emergence of resistant strains
thus narrowing the scope of chemotherapy. Notwithstanding the fact that emergence of resistance
is facilitated by the use of antibiotics (Levy, 2002) exposure to antibiotics is not a pre-requisite
for it. Antibiotic-resistance is detected even in bacteria occurring in places detached from the
human civilization for millions of years (Bhullar et al., 2012). The various mechanisms responsible
for antibiotic-resistance of bacteria were discussed in this journal some time back (Lin et al.,
2015). Outer Membrane Vesicles (OMVs) are spherical bag-like structures (20–300 nm) released
predominantly by gram-negative bacteria in the outer environment. They help the producer cells in
communication with other cells, secretion, pathogenesis, acquisition of nutrients, and self-defense
(Kulkarni and Jagannadham, 2014). Recent evidences indicate that they protect bacteria not only
from phages and various environmental stress factors but also some antibiotics. The nature of
vesicle-mediated antibiotic-resistance, known so far, is dealt with in this article.
Involvement of the Vesicles in Antibiotic Resistance
The OMVs mediate antibiotic resistance in various ways. In some cases they serve as vehicle for
the transport of antibiotic-inactivating enzyme. Using polyclonal antibodies against chromosomal
β-lactamase of P. aeruginosa and protein A-gold (Ciofu et al., 2000), demonstrated the presence of
β-lactamase in OMVs isolated from three β-lactam-resistant clinical isolates and one β-lactam-
sensitive strain of the bacterium. Gentamicin-induced increase in the vesicle formation by the
same organism was evidenced earlier (Kadurugamuwa and Beveridge, 1997). Thus it was indicated
that coupling of an aminoglycoside with a β-lactam antibiotic for the treatment of cystic fibrosis
patients might be counter-productive. Imipenem-induced stimulation in vesicle formation has
been recently demonstrated in the nosocomial pathogen Stenotrophomonas maltophilia. The
vesicles were found to contain both L1metallo-β-lactamase and L2 serine-β-lactamase (Devos et al.,
2015). Available evidences also indicate that vesicles containing β-lactamase confer protection not
only to the producer organism but also to some other bacteria co-occurring with the producer in
the human respiratory tract (Schaar et al., 2011, 2014). Recently, it has been demonstrated that
the β-lactamase associated with the vesicles produced by some members of the Bacteroides spp
protected some commensal and enteric pathogens (e.g., Salmonella typhimurium) from the third
generation cephalosporin cefotaxime. Species belonging to Bacteroides constitute a major fraction
of the human intestinal flora. Hence the clinical significance of this observation needs hardly to
be over-emphasized (Stentz et al., 2015). Bla Z, a β-lactamase protein was found to be associated
with the vesicles produced by a gram-positive organism, Staphylococcus aureus. Survival of some
Chattopadhyay and Jagannadham Vesicles-mediated resistance to antibiotics in bacteria
ampicillin-sensitive gram-positive and gram-negative organisms
incubated with the antibiotic was found to be mediated by
the vesicles (Lee et al., 2013). These findings underscore the
importance of OMVs in promoting emergence of resistant
strains out of a mixed community of bacteria. Immunoglobulin
G (IgG), produced against β-lactamase, is believed to inhibit
the enzyme and thus to render β-lactamase-positive bacteria
susceptible to the antibiotic. OMVs were found to protect β-
lactamase produced by Moraxella catarrhalis from inactivation
by anti-β-lactamase antibody by packaging the enzyme (Schaar
et al., 2013). It appears that the β-lactamases could be packaged
into the vesicles during the formation of the OMVs because of
their location in the periplasmic space of bacteria.
It was observed that the growth inhibitory effect of colistin
and melittin, two membrane-active antibiotics on an Antarctic
bacterium Pseudomoas syringae Lz4W, was reversed by the
addition of OMVs produced by the same organism, to the
culture medium. The binding of the antibiotics by the vesicles
was demonstrated by NPN-uptake assay. Proteomic analysis of
the vesicles revealed the presence of proteases and peptidases
in the OMVs, but no evidence of degradation of the two
peptide antibiotics was obtained. This it was evident that the
vesicles protected the bacterium by binding and removing the
antibiotics from the extracellular milieu. The protective effect of
the vesicles on the organism however was not observed against
streptomycin (Kulkarni et al., 2014). Bacterial membrane is
the major component of OMVs. Hence it appears that vesicles
could bind the peptide antibiotics because of their affinity
for membrane. On the other hand, the hydrophilic nature of
streptomycin might be responsible for inability of the vesicles
to bind it. Protective effect of the OMVs in E. coli against
two membrane-active antibiotics (polymixin B and colistin) was
evidenced earlier by the improved survival of a hypervesiculating
mutant in presence of the antibiotics compared to the growth of
the wild type strain challenged with the antibiotics. Vesiculation
was found to be induced in the wild type strain in presence of
the antibiotics and addition of purified vesicles to the wild type
culture was also associated with improved survival in presence of
the antibiotics. Similarly, survival of a strain of Enteropathogenic
E.coli (ETEC) in presence of polymixin B could be improved by
addition of vesicles produced by the strain to the culture medium
(Manning and Kuehn, 2011).
Fluoroquinolones are widely used for the suppression of the
mycoplasmas, which not only infect humans, animals, and plants
but also contaminate tissue cultures and vaccines. Mycoplasmas
rapidly develop resistance to the fluoroquinolone antibiotics. In
a recent study, vesicles produced by a ciprofloxacin-resistant
mutant of the mycoplasma Acholeplasma laidlawii were found
to contain ciprofloxacin. Thus, the OMVs appeared to protect
the bacterium from the antibiotic by removing it from the cell
and not allowing it to accumulate in sufficient concentration
required for its suppressive effect (Medvedeva et al., 2014). It
was demonstrated earlier that production of vesicles in E coli
was enhanced by increase in temperature andmisfolded proteins,
formed by heat stress, were packaged and removed from the cells
by the vesicles (McBroom andKuehn, 2007). Thus, OMVs appear
to help the producer organism in getting rid of toxic and injurious
substances by transporting them out of the cell.
Carbapenems are one of the last resorts for the clinical
management of antibiotic-resistant pathogens. It was observed
that the plasmid-borne blaOXA−24 gene, which encodes
a β-lactamase, responsible for carbapenem-resistance of
Acinetobacter baumannii, was present in the OMVs produced
by two clinical isolates of the organism. Following incubation
with these OMVs, a carbapenem-sensitive strain of the same
bacterium was found to acquire resistance. Subsequently it was
found to release OMVs containing the blaOXA−24 gene (Rumbo
et al., 2011). Transfer of penicillinase-specifying R plasmids
from antibiotic-resistant Neisseria gonorrhoeae to the wild-type
cells was demonstrated earlier (Dorward et al., 1989). The
vesicles produced by the mycoplasma in the above-mentioned
example were also found to contain a mutant version of the
gene that encodes ciprofloxacin-targeted protein (Medvedeva
et al., 2014). Hence OMVs could assume the role of a vector in
horizontal gene transfer that plays a crucial role in dissemination
of antibiotic-resistance among natural isolates.
Bacteria in biofilms are known to be more resistant to
antibiotics than their planktonic counterparts. A recent
proteomic analysis of OMVs obtained from planktonic
growth and biofilm in Pseudomonas aeruginosa revealed that
drug-binding proteins (notably eﬄux proteins) were more
concentrated in the biofilm OMVs. It is another example of
possible involvement of the vesicles in antibiotic resistance (Park
et al., 2014).
Scope for Further Studies
The active involvement of OMVs in antibiotic-resistance
of bacteria emphasizes the necessity of further in-depth
investigations on this aspect. Isolation of clinical samples of
antibiotic-resistant bacteria and analysis of the molecular profile
of the vesicles produced by them are likely to promise insight
into the molecular basis of the antibiotic-resistance. Search for
the inhibitors of vesicle formation (Tashiro et al., 2010) appears
to hold some promise in therapeutics since by suppressing vesicle
formation; they are likely to suppress both pathogenesis and
antibiotic-resistance of the pathogens.
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